Stockreport

TuHURA Biosciences, Inc.'s (NASDAQ:HURA) Shift From Loss To Profit [Yahoo! Finance]

TuHURA Biosciences, Inc.  (HURA) 
PDF TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. On 31 December 2025, th [Read more]